Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy
Technology appraisal guidance
Reference number: TA962
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.